Market Place
Sourcing Support
DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings
In 2022, the world finally began to emerge out of Covid-related
restrictions. Though 2020 and 2021
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Generic challenges, the next first-to-files, GDUFA dues (FY 2016) and more
PharmaCompass has assessed the second quarter US Drug Master
File (DMFs) filings. In our view, with
